Helmy Eltoukhy, Co-Chief Executive Officer at Guardant Health, Inc. (GH), sold 97,185 shares at $103.80 ($10.1M) on 2025-12-15, disclosed to the SEC on 2025-12-17.
Open-market sale of $10.1M GH by Co-Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $103.80 | 83,945 | $8.7M | 86.4% |
| 2 | $104.02 | 6,620 | $689K | 6.8% |
| 3 | $104.02 | 6,620 | $689K | 6.8% |
| Total | $103.83 avg | 97,185 | $10.1M | 100% |
| Filing → |
| GH | BUY | 2023-03-16 | $4.7M | — | Filing → |
| GH | BUY | 2021-11-23 | $17.7M | — | Filing → |
| GH | SELL | 2021-04-26 | $2.6M | — | Filing → |